FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

11005211000001102: Efalizumab 125mg powder and solvent for solution for injection vials 4 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37498501000001118 Efalizumab 125mg powder and solvent for solution for injection vials 4 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
37498601000001119 Efalizumab 125mg powder and solvent for solution for injection vials 4 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial Is pack of Efalizumab 125mg powder and solvent for solution for injection vials false Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial Has active ingredient Efalizumab false Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial Has manufactured dose form Powder and solvent for injection solution false Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial Has VMP Efalizumab 125mg powder and solvent for solution for injection vials true Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial Has specific active ingredient Efalizumab true Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial Has dispensed dose form Powder and solvent for solution for injection true Inferred relationship Existential restriction modifier
Efalizumab 125mg powder and solvent for solution for injection vials 4 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Raptiva 125mg powder and solvent for solution for injection vials (Serono Ltd) 4 vial Is a True Efalizumab 125mg powder and solvent for solution for injection vials 4 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start